Presumed airborne contact allergy to methylisothiazolinone causing acute severe facial dermatitis and respiratory difficulty-Reference-Cited by-同舟云学术

Presumed airborne contact allergy to methylisothiazolinone causing acute severe facial dermatitis and respiratory difficulty

Published:2014-04-15 Issue:5 Volume:70 Page:320-321
ISSN:0105-1873
Container-title:Contact Dermatitis
language:en
Short-container-title:Contact Dermatitis

Author:

Alwan Wisam¹,White Ian R.²,Banerjee Piu¹²

Affiliation:

1. Department of Dermatology; University Hospital Lewisham; Lewisham High Street London SE13 6LH UK

2. Department of Cutaneous Allergy; St Thomas' Hospital; Westminster Bridge Road London SE1 7EH UK

Publisher

Wiley

Subject

Dermatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cod.12219/fullpdf

Reference8 articles.

1. US Enviromental Protection Agency (EPA) Reregistration Eligibility Decision (RED) datasheet for methylisothiazolinone http://www.epa.gov/oppsrrd1/REDs/factsheets/3092fact.pdf

2. Outbreak of methylisothiazolinone allergy targeting those aged ≥ 40 years;McFadden;Contact Dermatitis,2013

3. Airborne exposure to preservative methylisothiazolinone causes severe allergic reactions;Lundov;Br Med J,2012

4. Presumed primary contact sensitization to methylisothiazolinone from paint: a chemical that became airborne;Kaae;Contact Dermatitis,2012

5. Contact dermatitis from methylisothiazolinone in a paint factory;Thyssen;Contact Dermatitis,2006

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review of the implications of construction materials on occupants’ physical and psychological health;Building and Environment;2024-06

2. Common Allergens;Clinical Contact Dermatitis;2021

3. Allergy to isothiazolinones in recent years;Medycyna Pracy;2020-09-24

4. History, Microhistory, and Sources of Contact Allergen Exposure;Common Contact Allergens;2019-11-15

5. Contact Allergy in Children with Atopic Dermatitis: A Retrospective Study;Endocrine, Metabolic & Immune Disorders - Drug Targets;2019-10-11